Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Avanos Medical (AVNS) Cash from Discontinued Operations (2018)

Avanos Medical's Cash from Discontinued Operations history spans 1 years, with the latest figure at 89900000.0 for Q2 2018.

On a quarterly basis, Cash from Discontinued Operations changed N/A to 89900000.0 in Q2 2018 year-over-year; TTM through Sep 2019 was 89900000.0, a 0.0% change, with the full-year FY2018 number at 98400000.0, changed N/A from a year prior.
Cash from Discontinued Operations hit 89900000.0 in Q2 2018 for Avanos Medical.
Over the last five years, Cash from Discontinued Operations for AVNS hit a ceiling of 89900000.0 in Q2 2018 and a floor of 89900000.0 in Q2 2018.